Loading…

The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease

A 47-year-old Japanese man was admitted to our hospital for evaluation of proteinuria, which was detected when he was 37 years of age. His creatinine clearance levels had fallen to 76.3 mL/min/1.73 m 2 . A kidney biopsy was conducted, and the patient’s low plasma α-galactosidase A levels suggested F...

Full description

Saved in:
Bibliographic Details
Published in:CEN case reports 2014-11, Vol.3 (2), p.152-157
Main Authors: Sakamaki, Yuichi, Maruyama, Hiroki, Homma, Noriyuki, Nakamura, Gen, Ito, Eiichi, Makino, Kunihiko, Yoshita, Kazuhiro, Ito, Yumi, Osawa, Yutaka, Imai, Naofumi, Ueno, Mitsuhiro, Miyazaki, Shigeru, Narita, Ichiei
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823
cites cdi_FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823
container_end_page 157
container_issue 2
container_start_page 152
container_title CEN case reports
container_volume 3
creator Sakamaki, Yuichi
Maruyama, Hiroki
Homma, Noriyuki
Nakamura, Gen
Ito, Eiichi
Makino, Kunihiko
Yoshita, Kazuhiro
Ito, Yumi
Osawa, Yutaka
Imai, Naofumi
Ueno, Mitsuhiro
Miyazaki, Shigeru
Narita, Ichiei
description A 47-year-old Japanese man was admitted to our hospital for evaluation of proteinuria, which was detected when he was 37 years of age. His creatinine clearance levels had fallen to 76.3 mL/min/1.73 m 2 . A kidney biopsy was conducted, and the patient’s low plasma α-galactosidase A levels suggested Fabry disease. After genetic counseling, GLA analysis revealed a novel mutation p.L387P. Interview with the patient revealed that both his younger brother and mother suffered from cardiomyopathy and were undergoing cardiological treatment. They also were positive for proteinuria. About 30 years ago, the patient’s cousin (aged 25) was diagnosed with Fabry disease. He underwent hemodialysis for 9 years until his death at 42. At that time, the patient and his brother had not been investigated for Fabry disease so their cousin could not act as a proband for the brothers. Eventually, the patient, his mother, and his brother were put on enzyme replacement therapy with agalsidase beta. As this series of cases shows, medical interviews to collate both medical and family history were essential for the discovery of Fabry disease in these patients. In addition, being a treatable genetic disorder, Fabry disease should be listed in the standard differential diagnoses of systemic and familial diseases, including unknown cause of nephropathy or cardiomyopathy, for early detection of the disorder.
doi_str_mv 10.1007/s13730-014-0108-3
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5411562</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1899406487</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823</originalsourceid><addsrcrecordid>eNp9kT1PwzAQhi0Eggr4ASzII0vAX4mTBQkVCohKLN3NNbm0Rklc7JSq_x5XAVQWBuss3XPvfbyEXHB2zRnTN4FLLVnCuIqP5Yk8ICPBC5EopYrDvf8JOQ_hnTHGpWIpK47Jichj5HkxIm-zJVLbrpzvoSuRupq2WNkSGmq7Hv2nxQ3d2H5Jxy_3dAW9xa6PKVpZWHQuYNiVAK2htc12ICcw99sIBISAZ-Sohibg-Xc8JbPJw2z8lExfH5_Hd9OkVCnvk0zqudKp0ExCluUgSplXmKVKc83jppUoSqgYk1zWKKAWCJJHPk0zrXMhT8ntILtaz-MCZZzSQ2NW3rbgt8aBNX8znV2ahfs0qeI8zXYCV98C3n2sMfSmtaHEpoEO3TqYeK1CsUzlOqJ8QEvvQvBY_7bhzOy8MYM3Jnpjdt4YGWsu9-f7rfhxIgJiAEJMdQv05t2tfRdP9o_qFzrlmSk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899406487</pqid></control><display><type>article</type><title>The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease</title><source>Springer Link</source><source>PubMed Central</source><creator>Sakamaki, Yuichi ; Maruyama, Hiroki ; Homma, Noriyuki ; Nakamura, Gen ; Ito, Eiichi ; Makino, Kunihiko ; Yoshita, Kazuhiro ; Ito, Yumi ; Osawa, Yutaka ; Imai, Naofumi ; Ueno, Mitsuhiro ; Miyazaki, Shigeru ; Narita, Ichiei</creator><creatorcontrib>Sakamaki, Yuichi ; Maruyama, Hiroki ; Homma, Noriyuki ; Nakamura, Gen ; Ito, Eiichi ; Makino, Kunihiko ; Yoshita, Kazuhiro ; Ito, Yumi ; Osawa, Yutaka ; Imai, Naofumi ; Ueno, Mitsuhiro ; Miyazaki, Shigeru ; Narita, Ichiei</creatorcontrib><description>A 47-year-old Japanese man was admitted to our hospital for evaluation of proteinuria, which was detected when he was 37 years of age. His creatinine clearance levels had fallen to 76.3 mL/min/1.73 m 2 . A kidney biopsy was conducted, and the patient’s low plasma α-galactosidase A levels suggested Fabry disease. After genetic counseling, GLA analysis revealed a novel mutation p.L387P. Interview with the patient revealed that both his younger brother and mother suffered from cardiomyopathy and were undergoing cardiological treatment. They also were positive for proteinuria. About 30 years ago, the patient’s cousin (aged 25) was diagnosed with Fabry disease. He underwent hemodialysis for 9 years until his death at 42. At that time, the patient and his brother had not been investigated for Fabry disease so their cousin could not act as a proband for the brothers. Eventually, the patient, his mother, and his brother were put on enzyme replacement therapy with agalsidase beta. As this series of cases shows, medical interviews to collate both medical and family history were essential for the discovery of Fabry disease in these patients. In addition, being a treatable genetic disorder, Fabry disease should be listed in the standard differential diagnoses of systemic and familial diseases, including unknown cause of nephropathy or cardiomyopathy, for early detection of the disorder.</description><identifier>ISSN: 2192-4449</identifier><identifier>EISSN: 2192-4449</identifier><identifier>DOI: 10.1007/s13730-014-0108-3</identifier><identifier>PMID: 28509189</identifier><language>eng</language><publisher>Tokyo: Springer Japan</publisher><subject>Case Report ; Medicine ; Medicine &amp; Public Health ; Nephrology ; Urology</subject><ispartof>CEN case reports, 2014-11, Vol.3 (2), p.152-157</ispartof><rights>Japanese Society of Nephrology 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823</citedby><cites>FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411562/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5411562/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,315,733,786,790,891,27957,27958,53827,53829</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28509189$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sakamaki, Yuichi</creatorcontrib><creatorcontrib>Maruyama, Hiroki</creatorcontrib><creatorcontrib>Homma, Noriyuki</creatorcontrib><creatorcontrib>Nakamura, Gen</creatorcontrib><creatorcontrib>Ito, Eiichi</creatorcontrib><creatorcontrib>Makino, Kunihiko</creatorcontrib><creatorcontrib>Yoshita, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Yumi</creatorcontrib><creatorcontrib>Osawa, Yutaka</creatorcontrib><creatorcontrib>Imai, Naofumi</creatorcontrib><creatorcontrib>Ueno, Mitsuhiro</creatorcontrib><creatorcontrib>Miyazaki, Shigeru</creatorcontrib><creatorcontrib>Narita, Ichiei</creatorcontrib><title>The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease</title><title>CEN case reports</title><addtitle>CEN Case Rep</addtitle><addtitle>CEN Case Rep</addtitle><description>A 47-year-old Japanese man was admitted to our hospital for evaluation of proteinuria, which was detected when he was 37 years of age. His creatinine clearance levels had fallen to 76.3 mL/min/1.73 m 2 . A kidney biopsy was conducted, and the patient’s low plasma α-galactosidase A levels suggested Fabry disease. After genetic counseling, GLA analysis revealed a novel mutation p.L387P. Interview with the patient revealed that both his younger brother and mother suffered from cardiomyopathy and were undergoing cardiological treatment. They also were positive for proteinuria. About 30 years ago, the patient’s cousin (aged 25) was diagnosed with Fabry disease. He underwent hemodialysis for 9 years until his death at 42. At that time, the patient and his brother had not been investigated for Fabry disease so their cousin could not act as a proband for the brothers. Eventually, the patient, his mother, and his brother were put on enzyme replacement therapy with agalsidase beta. As this series of cases shows, medical interviews to collate both medical and family history were essential for the discovery of Fabry disease in these patients. In addition, being a treatable genetic disorder, Fabry disease should be listed in the standard differential diagnoses of systemic and familial diseases, including unknown cause of nephropathy or cardiomyopathy, for early detection of the disorder.</description><subject>Case Report</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Nephrology</subject><subject>Urology</subject><issn>2192-4449</issn><issn>2192-4449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><recordid>eNp9kT1PwzAQhi0Eggr4ASzII0vAX4mTBQkVCohKLN3NNbm0Rklc7JSq_x5XAVQWBuss3XPvfbyEXHB2zRnTN4FLLVnCuIqP5Yk8ICPBC5EopYrDvf8JOQ_hnTHGpWIpK47Jichj5HkxIm-zJVLbrpzvoSuRupq2WNkSGmq7Hv2nxQ3d2H5Jxy_3dAW9xa6PKVpZWHQuYNiVAK2htc12ICcw99sIBISAZ-Sohibg-Xc8JbPJw2z8lExfH5_Hd9OkVCnvk0zqudKp0ExCluUgSplXmKVKc83jppUoSqgYk1zWKKAWCJJHPk0zrXMhT8ntILtaz-MCZZzSQ2NW3rbgt8aBNX8znV2ahfs0qeI8zXYCV98C3n2sMfSmtaHEpoEO3TqYeK1CsUzlOqJ8QEvvQvBY_7bhzOy8MYM3Jnpjdt4YGWsu9-f7rfhxIgJiAEJMdQv05t2tfRdP9o_qFzrlmSk</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Sakamaki, Yuichi</creator><creator>Maruyama, Hiroki</creator><creator>Homma, Noriyuki</creator><creator>Nakamura, Gen</creator><creator>Ito, Eiichi</creator><creator>Makino, Kunihiko</creator><creator>Yoshita, Kazuhiro</creator><creator>Ito, Yumi</creator><creator>Osawa, Yutaka</creator><creator>Imai, Naofumi</creator><creator>Ueno, Mitsuhiro</creator><creator>Miyazaki, Shigeru</creator><creator>Narita, Ichiei</creator><general>Springer Japan</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20141101</creationdate><title>The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease</title><author>Sakamaki, Yuichi ; Maruyama, Hiroki ; Homma, Noriyuki ; Nakamura, Gen ; Ito, Eiichi ; Makino, Kunihiko ; Yoshita, Kazuhiro ; Ito, Yumi ; Osawa, Yutaka ; Imai, Naofumi ; Ueno, Mitsuhiro ; Miyazaki, Shigeru ; Narita, Ichiei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Case Report</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Nephrology</topic><topic>Urology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sakamaki, Yuichi</creatorcontrib><creatorcontrib>Maruyama, Hiroki</creatorcontrib><creatorcontrib>Homma, Noriyuki</creatorcontrib><creatorcontrib>Nakamura, Gen</creatorcontrib><creatorcontrib>Ito, Eiichi</creatorcontrib><creatorcontrib>Makino, Kunihiko</creatorcontrib><creatorcontrib>Yoshita, Kazuhiro</creatorcontrib><creatorcontrib>Ito, Yumi</creatorcontrib><creatorcontrib>Osawa, Yutaka</creatorcontrib><creatorcontrib>Imai, Naofumi</creatorcontrib><creatorcontrib>Ueno, Mitsuhiro</creatorcontrib><creatorcontrib>Miyazaki, Shigeru</creatorcontrib><creatorcontrib>Narita, Ichiei</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>CEN case reports</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sakamaki, Yuichi</au><au>Maruyama, Hiroki</au><au>Homma, Noriyuki</au><au>Nakamura, Gen</au><au>Ito, Eiichi</au><au>Makino, Kunihiko</au><au>Yoshita, Kazuhiro</au><au>Ito, Yumi</au><au>Osawa, Yutaka</au><au>Imai, Naofumi</au><au>Ueno, Mitsuhiro</au><au>Miyazaki, Shigeru</au><au>Narita, Ichiei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease</atitle><jtitle>CEN case reports</jtitle><stitle>CEN Case Rep</stitle><addtitle>CEN Case Rep</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>3</volume><issue>2</issue><spage>152</spage><epage>157</epage><pages>152-157</pages><issn>2192-4449</issn><eissn>2192-4449</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>A 47-year-old Japanese man was admitted to our hospital for evaluation of proteinuria, which was detected when he was 37 years of age. His creatinine clearance levels had fallen to 76.3 mL/min/1.73 m 2 . A kidney biopsy was conducted, and the patient’s low plasma α-galactosidase A levels suggested Fabry disease. After genetic counseling, GLA analysis revealed a novel mutation p.L387P. Interview with the patient revealed that both his younger brother and mother suffered from cardiomyopathy and were undergoing cardiological treatment. They also were positive for proteinuria. About 30 years ago, the patient’s cousin (aged 25) was diagnosed with Fabry disease. He underwent hemodialysis for 9 years until his death at 42. At that time, the patient and his brother had not been investigated for Fabry disease so their cousin could not act as a proband for the brothers. Eventually, the patient, his mother, and his brother were put on enzyme replacement therapy with agalsidase beta. As this series of cases shows, medical interviews to collate both medical and family history were essential for the discovery of Fabry disease in these patients. In addition, being a treatable genetic disorder, Fabry disease should be listed in the standard differential diagnoses of systemic and familial diseases, including unknown cause of nephropathy or cardiomyopathy, for early detection of the disorder.</abstract><cop>Tokyo</cop><pub>Springer Japan</pub><pmid>28509189</pmid><doi>10.1007/s13730-014-0108-3</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2192-4449
ispartof CEN case reports, 2014-11, Vol.3 (2), p.152-157
issn 2192-4449
2192-4449
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5411562
source Springer Link; PubMed Central
subjects Case Report
Medicine
Medicine & Public Health
Nephrology
Urology
title The importance of medical interview with CKD patient in diagnoses of a family with Fabry disease
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T02%3A02%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20importance%20of%20medical%20interview%20with%20CKD%20patient%20in%20diagnoses%20of%20a%20family%20with%20Fabry%20disease&rft.jtitle=CEN%20case%20reports&rft.au=Sakamaki,%20Yuichi&rft.date=2014-11-01&rft.volume=3&rft.issue=2&rft.spage=152&rft.epage=157&rft.pages=152-157&rft.issn=2192-4449&rft.eissn=2192-4449&rft_id=info:doi/10.1007/s13730-014-0108-3&rft_dat=%3Cproquest_pubme%3E1899406487%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c451t-637b4752703a668a2c38de6547171137d29cad00313fe2af2ea3175255677823%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1899406487&rft_id=info:pmid/28509189&rfr_iscdi=true